Fischer Medical Ventures Ltd

Fischer Medical Ventures Ltd

₹ 36.2 -4.98%
01 Jun - close price
About

Incorporated in 1993, Fischer Chemic Ltd does trading of chemicals and machineries[1]

Key Points

Business Overview:[1]
Company is in the business of processing, manufacturing and trading of Laboratory Grade Chemicals

  • Market Cap 2,374 Cr.
  • Current Price 36.2
  • High / Low 125 / 32.0
  • Stock P/E 76.5
  • Book Value 5.88
  • Dividend Yield 0.01 %
  • ROCE 11.4 %
  • ROE 8.59 %
  • Face Value 1.00

Pros

  • Company is expected to give good quarter

Cons

  • Stock is trading at 6.16 times its book value
  • Company has a low return on equity of 5.54% over last 3 years.
  • Company has high debtors of 342 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
0.00 20.79 10.12 39.66 11.75 49.17 23.44 86.31 101.10 97.73
0.00 18.28 10.33 39.16 11.38 46.66 19.18 70.09 79.53 96.73
Operating Profit 0.00 2.51 -0.21 0.50 0.37 2.51 4.26 16.22 21.57 1.00
OPM % 12.07% -2.08% 1.26% 3.15% 5.10% 18.17% 18.79% 21.34% 1.02%
0.00 0.47 0.69 0.05 0.38 0.15 7.36 2.48 1.09 1.28
Interest 0.00 0.05 0.13 0.05 0.07 0.23 0.67 0.92 0.64 3.61
Depreciation 0.00 0.18 0.28 0.29 0.56 0.51 0.77 0.51 0.77 0.93
Profit before tax 0.00 2.75 0.07 0.21 0.12 1.92 10.18 17.27 21.25 -2.26
Tax % 6.18% 271.43% -38.10% 350.00% 26.04% 50.79% 19.46% 9.18% 214.60%
0.00 2.59 -0.12 0.29 -0.29 1.31 5.01 13.90 19.23 -7.10
EPS in Rs 0.00 0.05 -0.00 0.01 -0.01 0.02 0.08 0.21 0.30 -0.11
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025 Mar 2026
0 21 111 309
0 19 108 266
Operating Profit 0 2 3 43
OPM % 11% 9% 3% 14%
0 0 1 12
Interest 0 0 0 6
Depreciation 0 0 2 3
Profit before tax 0 2 2 47
Tax % 13% 45% 33%
-0 2 1 31
EPS in Rs -0.24 0.03 0.02 0.47
Dividend Payout % 0% 0% 22% 11%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 1097%
TTM: 179%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 820%
TTM: 2010%
Stock Price CAGR
10 Years: 67%
5 Years: 69%
3 Years: 45%
1 Year: -59%
Return on Equity
10 Years: %
5 Years: %
3 Years: 6%
Last Year: 9%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 0.17 54 64 65
Reserves -0 28 274 319
1 2 85 107
0 4 34 180
Total Liabilities 0 86 457 672
0 15 24 33
CWIP 0 0 1 3
Investments 0 1 11 123
0 70 421 513
Total Assets 0 86 457 672

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025 Mar 2026
-7 -87
-29 -125
37 315
Net Cash Flow 1 103
Free Cash Flow -8 -93
CFO/OP -392% -3,001%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 345 398 251 342
Inventory Days 99 36 32
Days Payable 48 82 263
Cash Conversion Cycle 345 449 205 111
Working Capital Days 324 498 40 155
ROCE % 5% 1% 11%

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Revenue from Consultancy & AMC
INR Lakhs ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Number of Permanent Employees
Number ・Standalone data
Health Screenings Conducted
Number
Target Educational Distribution (TAG Schools)
Number of Schools

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
0.00% 0.00% 0.00% 0.00% 74.91% 74.91% 74.91% 62.82% 61.80% 61.80% 61.80% 62.15%
0.00% 0.00% 0.00% 5.07% 5.07% 5.07% 5.07% 5.23% 5.55% 5.57% 4.85% 4.97%
0.00% 0.00% 0.00% 1.68% 1.68% 1.68% 1.68% 1.44% 1.42% 1.42% 1.36% 1.38%
99.99% 100.00% 99.99% 93.24% 18.33% 18.33% 18.32% 30.51% 31.23% 31.22% 31.99% 31.51%
No. of Shareholders 9,1009,1049,0388,9769,2859,5029,68810,18010,05813,05422,92023,269

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents